Appendix Fig. A3.

A summary of the trial design of NCT03617172, a phase II repurposing randomized controlled trial for the potency and efficacy of misoprostol to treat recurrent Clostridioides difficile infection.^A3 BID, twice per day; CDI, C. difficile infection; QID, four times per day; SAE, serious adverse event; SOC, standard of care.